These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 23432662

  • 21. Artepillin C, as a PPARγ ligand, enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS, Cha BY, Iida K, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT.
    Biochem Pharmacol; 2011 Apr 01; 81(7):925-33. PubMed ID: 21219874
    [Abstract] [Full Text] [Related]

  • 22. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
    Chen R, Wan J, Song J, Qian Y, Liu Y, Gu S.
    Pharm Biol; 2017 Dec 01; 55(1):503-509. PubMed ID: 27937122
    [Abstract] [Full Text] [Related]

  • 23. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS, Cha BY, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT.
    Life Sci; 2009 Jun 19; 84(25-26):908-14. PubMed ID: 19376135
    [Abstract] [Full Text] [Related]

  • 24. Identification of dual PPARα/γ agonists and their effects on lipid metabolism.
    Gao Q, Hanh J, Váradi L, Cairns R, Sjöström H, Liao VW, Wood P, Balaban S, Ong JA, Lin HY, Lai F, Hoy AJ, Grewal T, Groundwater PW, Hibbs DE.
    Bioorg Med Chem; 2015 Dec 15; 23(24):7676-84. PubMed ID: 26616289
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation.
    Ye F, Zhang ZS, Luo HB, Shen JH, Chen KX, Shen X, Jiang HL.
    Chembiochem; 2006 Jan 15; 7(1):74-82. PubMed ID: 16317783
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.
    Burgermeister E, Schnoebelen A, Flament A, Benz J, Stihle M, Gsell B, Rufer A, Ruf A, Kuhn B, Märki HP, Mizrahi J, Sebokova E, Niesor E, Meyer M.
    Mol Endocrinol; 2006 Apr 15; 20(4):809-30. PubMed ID: 16373399
    [Abstract] [Full Text] [Related]

  • 31. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
    Hamuro Y, Coales SJ, Morrow JA, Molnar KS, Tuske SJ, Southern MR, Griffin PR.
    Protein Sci; 2006 Aug 15; 15(8):1883-92. PubMed ID: 16823031
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling.
    Moyers JS, Shiyanova TL, Mehrbod F, Dunbar JD, Noblitt TW, Otto KA, Reifel-Miller A, Kharitonenkov A.
    J Cell Physiol; 2007 Jan 15; 210(1):1-6. PubMed ID: 17063460
    [Abstract] [Full Text] [Related]

  • 34. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.
    Keil S, Matter H, Schönafinger K, Glien M, Mathieu M, Marquette JP, Michot N, Haag-Diergarten S, Urmann M, Wendler W.
    ChemMedChem; 2011 Apr 04; 6(4):633-53. PubMed ID: 21400663
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A combined ligand- and structure-based virtual screening protocol identifies submicromolar PPARγ partial agonists.
    Vidović D, Busby SA, Griffin PR, Schürer SC.
    ChemMedChem; 2011 Jan 03; 6(1):94-103. PubMed ID: 21162086
    [Abstract] [Full Text] [Related]

  • 37. Structure-based identification of novel PPAR gamma ligands.
    da Silva FM, dos Santos JC, Campos JL, Mafud AC, Polikarpov I, Figueira AC, Nascimento AS.
    Bioorg Med Chem Lett; 2013 Nov 01; 23(21):5795-802. PubMed ID: 24075729
    [Abstract] [Full Text] [Related]

  • 38. Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.
    Schopfer FJ, Cole MP, Groeger AL, Chen CS, Khoo NK, Woodcock SR, Golin-Bisello F, Motanya UN, Li Y, Zhang J, Garcia-Barrio MT, Rudolph TK, Rudolph V, Bonacci G, Baker PR, Xu HE, Batthyany CI, Chen YE, Hallis TM, Freeman BA.
    J Biol Chem; 2010 Apr 16; 285(16):12321-33. PubMed ID: 20097754
    [Abstract] [Full Text] [Related]

  • 39. A Novel Partial PPARγ Agonist Has Weaker Lipogenic Effect in Adipocytes and Stimulates GLUT4 Translocation in Skeletal Muscle Cells via AMPK-Dependent Signaling.
    Guru B, Tamrakar AK, Mandal SP, Kumar PBR, Sharma A, Manjula SN.
    Pharmacology; 2022 Apr 16; 107(1-2):90-101. PubMed ID: 34736259
    [Abstract] [Full Text] [Related]

  • 40. A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity.
    Choi SS, Kim ES, Koh M, Lee SJ, Lim D, Yang YR, Jang HJ, Seo KA, Min SH, Lee IH, Park SB, Suh PG, Choi JH.
    J Biol Chem; 2014 Sep 19; 289(38):26618-26629. PubMed ID: 25100724
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.